Fuller & Thaler Asset Management
GMED icon

Fuller & Thaler Asset Management’s Globus Medical GMED Stock Holding History

Fuller & Thaler Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.9M Buy
1,101,568
+66,050
+6% +$5.93M 0.32% 111
2025
Q4 		$90.4M Buy
+1,035,518
New +$78.6M 0.31% 118
2025
Q3 		– Sell
-113
Closed -$6.67K – 537
2025
Q2 		$6.67K Sell
113
-919,115
-100% -$59.4M ﹤0.01% 578
2025
Q1 		$67.3M Buy
919,228
+195,827
+27% +$16.2M 0.26% 141
2024
Q4 		$59.8M Buy
723,401
+59,997
+9% +$4.73M 0.23% 151
2024
Q3 		$47.5M Buy
663,404
+87,824
+15% +$6.2M 0.19% 170
2024
Q2 		$39.4M Buy
575,580
+442,099
+331% +$26.4M 0.17% 178
2024
Q1 		$7.16M Sell
133,481
-427,609
-76% -$23M 0.03% 291
2023
Q4 		$29.9M Buy
561,090
+460,937
+460% +$22.5M 0.15% 168
2023
Q3 		$4.97M Sell
100,153
-388
-0.4% -$21.7K 0.03% 289
2023
Q2 		$5.99M Buy
100,541
+391
+0.4% +$22.3K 0.03% 281
2023
Q1 		$5.67M Sell
100,150
-409,035
-80% -$26.2M 0.03% 278
2022
Q4 		$37.8M Buy
509,185
+787
+0.2% +$53.6K 0.24% 135
2022
Q3 		$30.3M Buy
508,398
+982
+0.2% +$59.1K 0.22% 134
2022
Q2 		$28.5M Sell
507,416
-1,835
-0.4% -$121K 0.2% 151
2022
Q1 		$37.6M Buy
509,251
+148,621
+41% +$10.3M 0.22% 142
2021
Q4 		$26M Buy
360,630
+75,323
+26% +$5.47M 0.15% 162
2021
Q3 		$21.9M Buy
+285,307
New +$22.9M 0.14% 155
2021
Q1 		– Sell
-160,879
Closed -$10.5M – 545
2020
Q4 		$10.5M Buy
160,879
+3,545
+2% +$204K 0.1% 199
2020
Q3 		$7.79M Buy
+157,334
New +$8.12M 0.1% 195
2017
Q1 		– Sell
-450
Closed -$11K – 715
2016
Q4 		$11K Hold
450
– – ﹤0.01% 713
2016
Q3 		$10K Buy
+450
New +$10.6K ﹤0.01% 744
2014
Q3 		– Sell
-4,400
Closed -$105K – 677
2014
Q2 		$105K Sell
4,400
-3,600
-45% -$86.8K ﹤0.01% 590
2014
Q1 		$213K Buy
+8,000
New +$190K 0.01% 425

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management's GMED Position: Q1 2026 in Review

Fuller & Thaler Asset Management increased its Globus Medical (GMED) stake by 6.4% in Q1 2026, buying an estimated $5.93M and bringing the position to 1,101,568 shares worth $94.9M. The position accounts for 0.32% of the portfolio, ranked #111.

Fuller & Thaler Asset Management first reported a position in GMED in Q1 2014 and has held it in 24 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Fuller & Thaler Asset Management held 1,101,568 shares of Globus Medical worth $94.9M as of Q1 2026.
  • Fuller & Thaler Asset Management bought 66,050 Globus Medical shares in Q1 2026, an estimated $5.93M.
  • Globus Medical made up 0.32% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #111 holding.
  • Fuller & Thaler Asset Management first reported a position in Globus Medical in Q1 2014 and has held it in 24 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.